We are pleased to announce that the 39^th PAGJa Annual Meeting will be held on 17^th November 2023 at Fujiwara Hiroshi Hall, Kyoseikan, Keio University (Yokohama, Kanagawa; please see https://www.kcc.keio.ac.jp/english/access.html).

If you would like to participate, please register from this link or send an e-mail to the conference chair (pmx2023@pagja.org). The advanced registration deadline is 10th November 2023.

Registration Fee

PAGJa 2023: Free for student, and 5,000 JPY for non-student.
Reception Party: 3,000 JPY for student, and 5,000 JPY for non-student.

Program

12:30-12:35 pm Opening Remarks

12:35-1:35 pm Educational Session

Establishing Trust and Confidence in Physiologically-Based Pharmacokinetic Models Using the Credibility Assessment Framework

Christopher Gibson, Merck & Co.

1:35-2:25 pm General Oral Presentation Session (Presented in Japanese only)

Population Pharmacokinetic Analysis for Evaluating Effect of Ethnicity on Esketamine Pharmacokinetics

Minaka Shibuya, Janssen Pharmaceutical of Johnson and Johnson

Population Pharmacokinetic Analysis Considering an Absorption Process of Mycophenolic acid

Yuki Suzuki, Nihon University

Integrated Population Pharmacokinetic Model Development of Vancomycin Applied to Diverse Patient Characteristics

Moeko Suzuki, Tokyo Women’s Medical University Hospital

2:40-3:40 pm Keynote Lecture

Convergence – Reshaping the future of Healthcare Analytics

Vijay Ivaturi, University of Maryland

3:40-5:50 pm PMDA session 2023: Industry, Government and Academia Round-table Discussion on Pharmacometrics in Pediatric Drug Development (Presented in Japanese; simultaneous translation into English will be planned for English Speaker)

Utilization of Pharmacometrics and Trends of Related Guidelines for Pediatric Drug Development

Shingo Watanabe, Pharmaceuticals and Medical Devices Agency

Optimal Dose Recommendation in Pediatrics using Pharmacometrics

Keizo Fukushima, Kobe Gakuin University

Utilization of Pharmacometrics for Drug Development of Rivaroxaban for Pediatrics Patients

Yui Terao, Bayer Yakuhin

Panel Discussion

5:50-6:00 pm Closing Remarks

6:10-8:00 pm Reception Party

Please feel free to contact to the conference chair if you have any questions. We look forward to seeing you at the meeting.

The 39^th PAGJa Conference Chair

Satoshi Yoshiba (Daiichi Sankyo)

Yuki Iwaki (Janssen Pharmaceutical of Johnson and Johnson)

E-mail: pmx2023@pagja.org